Copertina

AI-driven Alternative Medicine: A Novel Approach to Drug Discovery and Repurposing

Fuente: arXiv

Salvato in:

Dettagli Bibliografici
Autori principali:	Bilokon, Oleksandr, Bilokon, Nataliya, Bilokon, Paul
Natura:	Preprint
Pubblicazione:	2024
Soggetti:	Biomolecules
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

A Sieve on Rational Imbalances and the First Appearance of Denominators
di: Bilokon, Paul Alexander
Pubblicazione: (2025)

Evolution-Bootstrapped Simulation: Artificial or Human Intelligence: Which Came First?
di: Bilokon, Paul Alexander
Pubblicazione: (2024)

On the Density of Prime Imbalances in the Unit Interval
di: Bilokon, Paul Alexander
Pubblicazione: (2025)

Imbalance Prime Sieving: Every Prime Gap Is a Result of a Möbius Imbalance Obstruction
di: Bilokon, Paul Alexander
Pubblicazione: (2025)

Simultaneous Novelty from First-Appearance Times in the Calkin-Wilf Enumeration
di: Bilokon, Paul Alexander
Pubblicazione: (2025)

Computation as a Game
di: Bilokon, Paul Alexander
Pubblicazione: (2025)

All You Need is Amplifier: Spectral Imposters Without Pulse Shaping
di: Bilokon, Valeriia, et al.
Pubblicazione: (2026)

Dispersion Relations in Two- and Three-Dimensional Quantum Systems
di: Bilokon, Valeriia, et al.
Pubblicazione: (2025)

DrugCLIP: Contrastive Drug-Disease Interaction For Drug Repurposing
di: Lu, Yingzhou, et al.
Pubblicazione: (2024)

Towards spintronics via tunneling through asymmetric barriers
di: Bilokon, Elvira, et al.
Pubblicazione: (2026)

Artificial Intelligence Approaches for Anti-Addiction Drug Discovery
di: Chen, Dong, et al.
Pubblicazione: (2025)

Hilbert Space Black Hole Analog: Unidirectional Transport without Driving
di: Bilokon, Elvira, et al.
Pubblicazione: (2026)

On Novel Approach for Computing Distance based Indices of Anti-tuberculosis Drugs
di: Gunawardhana, D. C., et al.
Pubblicazione: (2024)

Drug Repurposing Targeting COVID-19 3CL Protease using Molecular Docking and Machine Learning Regression Approach
di: Aqeel, Imra, et al.
Pubblicazione: (2023)

Graph Neural Networks in Modern AI-aided Drug Discovery
di: Zhang, Odin, et al.
Pubblicazione: (2025)

K-Paths: Reasoning over Graph Paths for Drug Repurposing and Drug Interaction Prediction
di: Abdullahi, Tassallah, et al.
Pubblicazione: (2025)

Interpreting GFlowNets for Drug Discovery: Extracting Actionable Insights for Medicinal Chemistry
di: S, Amirtha Varshini A, et al.
Pubblicazione: (2025)

Few-fermion resonant tunneling and underbarrier trapping in asymmetric potentials
di: Bilokon, Elvira, et al.
Pubblicazione: (2024)

Universal Relation Between Quantum Entanglement and Particle Transport
di: Bilokon, Elvira, et al.
Pubblicazione: (2025)

DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery
di: Li, Kun, et al.
Pubblicazione: (2025)

Pharmacology Knowledge Graphs: Do We Need Chemical Structure for Drug Repurposing?
di: Abo-Dahab, Youssef, et al.
Pubblicazione: (2026)

How Evaluation Choices Distort the Outcome of Generative Drug Discovery
di: Özçelik, Rıza, et al.
Pubblicazione: (2024)

Conditional Chemical Language Models are Versatile Tools in Drug Discovery
di: Zhu, Lu, et al.
Pubblicazione: (2025)

Conditioned Generative Modeling of Molecular Glues: A Realistic AI Approach for Synthesizable Drug-like Molecules
di: Islam, Naeyma N., et al.
Pubblicazione: (2026)

Drug Repurposing for Parkinson's Disease Using Random Walk With Restart Algorithm and the Parkinson's Disease Ontology Database
di: Kankariya, Pratham, et al.
Pubblicazione: (2024)

Site4Drug: Predicting Drug-Binding Target Sites with an AI Agent
di: Kim, Taehan, et al.
Pubblicazione: (2026)

Quantum-machine-assisted Drug Discovery
di: Zhou, Yidong, et al.
Pubblicazione: (2024)

Real-time VaR Calculations for Crypto Derivatives in kdb+/q
di: Chen, Yutong, et al.
Pubblicazione: (2023)

Mitigating Molecular Aggregation in Drug Discovery with Predictive Insights from Explainable AI
di: Sturm, Hunter, et al.
Pubblicazione: (2023)

Graph-structured Small Molecule Drug Discovery Through Deep Learning: Progress, Challenges, and Opportunities
di: Li, Kun, et al.
Pubblicazione: (2025)

PKAG-DDI: Pairwise Knowledge-Augmented Language Model for Drug-Drug Interaction Event Text Generation
di: Wang, Ziyan, et al.
Pubblicazione: (2025)

Systems-Structure-Based Drug Design
di: Zaballa, Vincent D., et al.
Pubblicazione: (2024)

Quantum Long Short-Term Memory for Drug Discovery
di: Zhang, Liang, et al.
Pubblicazione: (2024)

Repurformer: Transformers for Repurposing-Aware Molecule Generation
di: Lee, Changhun, et al.
Pubblicazione: (2024)

Latent-Y: A Lab-Validated Autonomous Agent for De Novo Drug Design
di: Latent Labs Team, et al.
Pubblicazione: (2026)

A Heterogeneous Network-based Contrastive Learning Approach for Predicting Drug-Target Interaction
di: Hu, Junwei, et al.
Pubblicazione: (2024)

A Foundation Chemical Language Model for Comprehensive Fragment-Based Drug Discovery
di: Ho, Alexander, et al.
Pubblicazione: (2025)

FlexSBDD: Structure-Based Drug Design with Flexible Protein Modeling
di: Zhang, Zaixi, et al.
Pubblicazione: (2024)

Discrimination vs. Generation: The Machine Learning Dichotomy for Dopaminergic Hit Discovery
di: Sobodu, Temitope, et al.
Pubblicazione: (2024)

Hybrid Quantum Generative Adversarial Networks for Molecular Simulation and Drug Discovery
di: Jain, Prateek, et al.
Pubblicazione: (2022)